Krystal Biotech, Inc.

KRYS · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Assets
Cash & Equivalents$392,604$353,829$308,770$344,865
Short-Term Investments$338,465$328,157$308,076$252,652
Receivables$129,633$111,439$103,260$104,746
Inventory$37,632$31,041$29,942$26,508
Other Curr. Assets$17,213$16,881$16,750$13,274
Total Curr. Assets$925,650$841,347$766,798$742,045
Property Plant & Equip (Net)$156,318$158,043$158,928$161,448
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$133,113$138,807$148,472$152,114
Tax Assets$24,680$0$0$0
Other NC Assets$333$197$218$231
Total NC Assets$314,444$297,047$307,618$313,793
Other Assets$0$0$0$0
Total Assets$1,240,094$1,138,394$1,074,416$1,055,838
Liabilities
Payables$2,097$7,124$2,672$4,985
Short-Term Debt$0$0$0$0
Tax Payable$0$8,298$11,429$4,288
Deferred Revenue$0$0$0$0
Other Curr. Liab.$3,284$2,173$3,388$2,403
Total Curr. Liab.$91,268$86,896$79,489$101,995
LT Debt$0$0$0$0
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$3,137$2,787$1,953$1,419
Total NC Liab.$10,950$10,851$10,253$7,463
Other Liabilities$0$0$0$0
Cap. Leases$0$9,681$9,662$7,261
Total Liabilities$102,218$97,747$89,742$109,458
Equity
Pref Stock$0$0$0$0
Common Stock$0$0$0$0
Retained Earnings-$27,237-$106,602-$144,935-$180,668
AOCI$1,100$1,157$390-$190
Other Equity$0$0$0$0
Total Equity$1,137,876$1,040,647$984,674$946,380
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$1,240,094$1,138,394$1,074,416$1,055,838
Net Debt-$392,604-$353,829-$308,770-$344,865
Krystal Biotech, Inc. (KRYS) Financial Statements & Key Stats | AlphaPilot